UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000043297
Receipt No. R000049411
Scientific Title Cancer morbidity in patients with cardiac dysfunction with left ventricular ejection fraction <50%
Date of disclosure of the study information 2021/02/10
Last modified on 2022/08/13 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Cancer morbidity in patients with cardiac dysfunction with left ventricular ejection fraction <50%
Acronym Cancer morbidity in patients with cardiac dysfunction
Scientific Title Cancer morbidity in patients with cardiac dysfunction with left ventricular ejection fraction <50%
Scientific Title:Acronym Cancer morbidity in patients with cardiac dysfunction
Region
Japan

Condition
Condition heart failure
Classification by specialty
Cardiology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To identify the cancer morbidity of patients with cardiac dysfunction
Basic objectives2 Others
Basic objectives -Others Descriptive study
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Cancer morbidity of patients with cardiac dysfunction
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
65 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with echocardiographic evidence of left ventricular ejection fraction of 50% or less
Key exclusion criteria None
Target sample size 3000

Research contact person
Name of lead principal investigator
1st name Shinya
Middle name
Last name Fujiki
Organization Niigata University Graduate School of Medical and Dental Sciences
Division name Department of Cardiovascular Biology and Medicine
Zip code 951-8510
Address 1-757 Asahimachidori, Chuo-ku, Niigata
TEL 025-227-2185
Email sfujiki@med.niigata-u.ac.jp

Public contact
Name of contact person
1st name Shinya
Middle name
Last name Fujiki
Organization Niigata University Graduate School of Medical and Dental Sciences
Division name Department of Cardiovascular Biology and Medicine
Zip code 951-8510
Address 1-757 Asahimachidori, Chuo-ku, Niigata
TEL 025-227-2185
Homepage URL
Email sfujiki@med.niigata-u.ac.jp

Sponsor
Institute Niigata University
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization The ethical committees of Niigata University
Address 1-757 Asahimachidori, Chuo-ku, Niigata
Tel 025-227-2625
Email ethics@adm.niigata-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 02 Month 10 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2019 Year 06 Month 20 Day
Date of IRB
2019 Year 07 Month 22 Day
Anticipated trial start date
2019 Year 08 Month 01 Day
Last follow-up date
2022 Year 03 Month 31 Day
Date of closure to data entry
2022 Year 10 Month 31 Day
Date trial data considered complete
Date analysis concluded

Other
Other related information 1. Gender, age, past history, comorbidities, medication
2. Date of onset, type of cancer
3. Height, weight, vital signs
4. Blood test
5. 12 Lead ECG
6. Echocardiography

Management information
Registered date
2021 Year 02 Month 10 Day
Last modified on
2022 Year 08 Month 13 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000049411